Company patents
Withings
Withings' patent strategy, surprisingly, shows a strong and growing focus on core medical device innovation, with Medical Diagnostics & Surgery patents accounting for 51.9% of its portfolio and experiencing a 25.0% YoY growth in 2025, despite a partial decline so far in 2026. Concurrently, an emerging focus on Material & Chemical Analysis is evident, with this category showing a rapid 66.7% YoY growth in 2025, suggesting an expansion beyond purely diagnostic devices into underlying material science.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
77 US filings (since 2023) · 5 categories · 4 themes
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Self-contained or modular devices designed to automate and integrate multiple steps of molecular diagnostic assays, from sample preparation to result interpretation, often for point-of-care or high-throughput applications.
Miniaturized devices that manipulate small volumes of fluids (nanoliters to picoliters) through microchannels to perform laboratory functions like mixing, separation, reaction, and detection on a single chip.
Patents
Showing 1-10 of 26
Wearable Physiological Sensing